With the recent literature available on novel biomarkers identified in septic AKI, we have conducted a prospective study in a surgical intensive care unit, investigating the use of NGAL, calprotectin, KIM-1, cystatin-C, and GDF-15 in combination with SOFA to improve early recognition of such patients. The gene discussed is CST3; the disease is acute kidney injury.